Group 1 - The company, China Feihe, forecasts a revenue of approximately 9.1 billion to 9.3 billion RMB and a net profit of about 1 billion to 1.2 billion RMB for the first half of 2025 [1] - Feihe plans to utilize no less than 1 billion RMB for share repurchase and maintains a stable dividend policy, expecting to distribute a total dividend of no less than 2 billion RMB in 2025 [1] - The company's share repurchase and continuous dividends reflect its strong performance and cash flow, showcasing confidence in its intrinsic value and industry potential despite challenges [1] Group 2 - Feihe has initiated a 1.2 billion RMB maternity subsidy plan to support eligible families, demonstrating its commitment to social responsibility [1] - The company emphasizes "technological innovation" as a key driver for development, having launched a "milk protein fresh extraction technology" and established a comprehensive database for HMOs, achieving international leading standards [1] - Feihe is expanding its product offerings under the "full lifecycle nutrition" strategy, including new products like the Aiben protein nutrition powder, and is accelerating its internationalization efforts with the launch of its infant formula in Canada [2]
中国飞鹤：拟启动10亿元回购计划，彰显未来发展信心